Chemours Company Adopts Executive Severance Policy
2025-10-31SEC Filing 8-K (0001193125-25-260863)
On October 28, 2025, The Chemours Company's Board of Directors approved the Executive Severance Policy, effective immediately. The policy provides severance benefits to executive officers and certain employees upon specified terminations of employment. Participants must execute a release of claims to be eligible for benefits. The policy outlines specific compensation for the CEO and other executive officers, including accrued obligations, cash severance payments, and prorated annual incentive awards. The policy does not supersede existing change in control agreements or equity award terms. The full details of the policy are included in Exhibit 10.1 of the filing.
Tickers mentioned in this filing:CC
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1627223/0001193125-25-260863.txt